Exelixis (EXEL) Long-Term Deferred Tax (2018 - 2026)

Exelixis (EXEL) recorded quarterly Long-Term Deferred Tax of $293.7 million in Q2 2026, little changed quarter-over-quarter from $292.6 million in Q1 2026, and down 29.9% on a YoY basis from $419.0 million in Q2 2025.

Exelixis (EXEL) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends

Exelixis' Long-Term Deferred Tax history runs 9 years deep, the most recent figure standing at $293.7 million for Q2 2026.

  • In Q2 2026, Long-Term Deferred Tax fell 29.9% year-over-year to $293.7 million; the TTM figure through Apr 2026 stood at $293.7 million (down 29.9% YoY), while the FY2026 annual figure was $292.6 million, down 30.34% from the prior year.
  • Long-Term Deferred Tax was $293.7 million for Q2 2026 at Exelixis, roughly flat from $292.6 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $420.0 million in Q1 2025 to a low of $98.0 million in Q2 2022.
  • Historically, Long-Term Deferred Tax has averaged $291.6 million across 5 years, with a median of $293.7 million in 2026.
  • The sharpest annual moves came in 2022 and 2023: Long-Term Deferred Tax sank 38.98% in 2022, then surged 134.29% in 2023.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $231.1 million in 2022, then soared by 56.27% to $361.1 million in 2023, then declined by 0.63% to $358.9 million in 2024, then gained by 16.64% to $418.6 million in 2025, then dropped by 29.83% to $293.7 million in 2026.
  • The last three Long-Term Deferred Tax figures came in at $293.7 million (Q2 2026), $292.6 million (Q1 2026), and $418.6 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Exelixis 13.72 Bn 12.95 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 293.73 Mn
Jan 2, 2026 292.58 Mn
Oct 3, 2025 418.58 Mn
Jul 4, 2025 419.24 Mn
Apr 4, 2025 419.05 Mn
Jan 3, 2025 420.03 Mn
Sep 27, 2024 358.87 Mn
Jun 28, 2024 361.56 Mn
Mar 29, 2024 361.58 Mn
Dec 29, 2023 361.15 Mn
Sep 29, 2023 230.99 Mn
Jun 30, 2023 231.12 Mn
Mar 31, 2023 229.60 Mn
Dec 30, 2022 231.11 Mn
Sep 30, 2022 116.42 Mn
Jul 1, 2022 113.96 Mn
Apr 1, 2022 98.00 Mn
Dec 31, 2021 111.66 Mn
Oct 1, 2021 125.30 Mn
Jul 2, 2021 134.67 Mn